SCHEMBL7145386

SCHEMBL7145386

CN(CCO)c1cc(NC(=O)OC(C)(C)C)c([N+](=O)[O-])cc1I

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 1/20 0.47
MMP1 P03956 2/20 0.35
MMP2 P08253 2/20 0.35
MMP9 P14780 2/20 0.35
MMP8 P22894 2/20 0.35
MMP13 P45452 2/20 0.35
MAPT P10636 2/20 0.35
HCAR3 P49019 1/20 0.34
TSHR P16473 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
NPC1 O15118 1/20 0.33
GLA P06280 1/20 0.33
MAPK1 P28482 1/20 0.33
CASP3 P42574 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6165036 0.87 MAPT (0.40) ALDH1A1MMP1MMP2MMP9MMP8
SCHEMBL7145353 0.81 HCAR3 (0.33) ALDH1A1MMP1MMP2MMP9MMP8
SCHEMBL30235399 0.80 ALDH1A1 (0.52) ALDH1A1KDM4EMMP1MMP2MMP9
SCHEMBL7145307 0.80 KMT2A (0.37) ALDH1A1MMP1MMP2MMP9MMP8
SCHEMBL6164659 0.80 HCAR3 (0.44) ALDH1A1KDM4EMAPTHCAR3SMN1; SMN2
SCHEMBL5558433 0.79 HCAR3 (0.42) ALDH1A1KDM4EHCAR3TSHRTDP1
SCHEMBL7138005 0.79 MAPT (0.42) ALDH1A1MAPTHCAR3TSHRTDP1
SCHEMBL7145468 0.79 MMP1 (0.39) ALDH1A1MMP1MMP2MMP9MMP8
SCHEMBL6165488 0.79 HCAR3 (0.43) ALDH1A1KDM4EMAPTHCAR3SMN1; SMN2
SCHEMBL7147497 0.78 KCNMA1 (0.41) ALDH1A1MMP1MMP2MMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed